artus C. difficile QS-RGQ Kit CE
For qualitative detection of toxigenic Clostridium difficile toxin A and toxin B genes
The artus C. difficile QS-RGQ Kit delivers sensitive and specific detection of both Clostridium difficile toxins genes A and B giving you the definitive results you need. The kit is a ready-to-use PCR assay for use on the QIAsymphony RGQ and provides all necessary reagents optimized for the direct qualitative detection of toxigenic C. difficile toxin A and toxin B genes in human liquid or soft stool for in vitro diagnostic use.
The artus C. difficile QS-RGQ Kit CE is intended for in vitro diagnostic use in Europe.
See the online Performance Characteristics.
The artus C. difficile QS-RGQ Kit constitutes a ready-to-use system for the detection of toxigenic C. difficile toxin A and toxin B genes using real-time PCR on Rotor-Gene Q instruments with sample preparation and assay setup using QIAsymphony SP/AS instruments. The C. difficile Master A and C. difficile Master B contain reagents and enzymes for the specific amplification of target regions within the tcdA, tcdB, and tcdBv genes of toxigenic C. difficile genomes and for the direct detection of the specific amplicon in fluorescence channels Cycling Orange and Cycling Green of Rotor-Gene Q instruments.
In addition, the artus C. difficile QS-RGQ Kit contains a second heterologous control system to identify potential failures during the entire assay process. This is detected as an internal control (IC) in fluorescence channel Cycling Crimson of Rotor-Gene Q instruments.
The QIAsymphony RGQ complete workflow solution for detection of C. difficile DNA comprises the QIAsymphony SP and QIAsymphony DSP Virus/Pathogen Mini Kit for sample preparation, the QIAsymphony AS for assay setup, the artus C. difficile QS-RGQ Kit on Rotor-Gene Q instruments for detection, and Rotor-Gene AssayManager for automated interpretation of results. The system enables reliable pathogen DNA detection with a complete CE-IVD-compliant workflow.
The artus C. difficile QS-RGQ Kit enables rapid and sensitive detection of toxigenic Clostridium difficile toxin A and toxin B genes in human liquid or soft stool from patients suspected of having Clostridium difficile associated disease. The test is intended to be used directly on patient samples to aid in diagnosis of Clostridium difficile infection.
The artus C. difficile QS-RGQ Kit is designed to be used with the QIAsymphony RGQ, providing a complete CE-IVD-compliant workflow, from sample to result.